2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | Pre 2008
All links are courtesy of PubMed unless otherwise stated.
The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.
Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series.
Hospitalisations with Hidradenitis Suppurativa: An Increasing Problem That Deserves Closer Attention.
Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literature.
Adalimumab: A Review in Hidradenitis Suppurativa.
Successful treatment of widespread chronic gluteal hidradenitis suppurativa with combination of recycled skin graft and negative-pressure wound therapy.
High Prevalence of Back Pain and Axial Spondyloarthropathy in Patients with Hidradenitis Suppurativa.
NCSTN mutations in hidradenitis supprativa/acne inversa do not influence cytokine production by peripheral blood mononuclear cells.
Hidradenitis suppurativa patients have no increased risk of Alzheimer's disease.
Should hidradenitis suppurativa/ acne inversa best be renamed as "dissecting terminal hair folliculitis"?
Bilateral Pedicled Superficial Inferior Epigastric Artery Flap in the Treatment of Hidradenitis Suppurativa.
Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
Accelerated wound healing after wide excisions in Hidradenitis Suppurativa using autologous split-thickness skin grafting and platelet-rich plasma.
Hidradenitis suppurativa is not associated with the metabolic syndrome based on body type: A cross-sectional study.
Management of hidradenitis suppurativa.
Phenotypic Characterization of Patients with Hidradenitis Suppurativa.
Reply to Lipsker et al. and Revuz on Hidradenitis Suppurativa Terminology: The Imaging Point of View.
Hidradenitis Suppurativa and the Association With Hematological Malignancies: A Review of 2 Cases.
Bacterial Biofilm in Chronic Lesions of Hidradenitis Suppurativa.
Discussion: What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both?
What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both?
Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
Regional variation of hidradenitis suppurativa in the Norwegian Patient Registry during a 5-year period may describe professional awareness of the disease, not changes in prevalence.
Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
Hidradenitis suppurativa: A disease of infundibular epidermis, rather than pilosebaceous units?
The Association between Hidradenitis Suppurativa and Crohn's Disease: in Search of the Missing Pathogenic Link.
Hidradenitis Suppurativa: Review of the Pathogenesis and Treatment.
Hidradenitis suppurativa: development of outcome measure instruments.
Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group.
High burden of hospital resource utilisation in patients with hidradenitis suppurativa in England: A retrospective cohort study using hospital episode statistics.
Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicenter cross-sectional study.
Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
HIDRADENITIS SUPPURATIVA: A CASE SERIES OF EIGHT PATIENTS.
Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
A systematic review of the use of lasers for the treatment of hidradenitis suppurativa.
Hidradenitis suppurativa associated with squamous cell carcinoma: an example of an isoscartopic response.
Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report.
A pilot study of unemployment in Hidradenitis Suppurativa Patients in Denmark.
Hidradenitis suppurativa: haploinsufficiency of gamma-secretase components does not affect gamma-secretase enzyme activity in vitro.
Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Prevalence of Firmicutes in Lesions of Hidradenitis Suppurativa in Obese Patients.
Acitretin: Monotherapy or Combined Therapy for Hidradenitis Suppurativa?
Increased total serum IgE levels in moderate-to-severe hidradenitis suppurativa.
Successful use of brachytherapy for a severe hidradenitis suppurativa variant.
Photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective follow-up study in 7 patients and a review of the literature.
Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab.
A severe case of hidradenitis suppurativa.
Adalimumab (Humira) for the Treatment of Hidradenitis Suppurativa.
Finasteride in Hidradenitis Suppurativa: A "Male" Therapy for a Predominantly "Female" Disease.
Managing patients with hidradenitis suppurativa.
Marjolin's Ulcer in Chronic Hidradenitis Suppurativa: A Rare Complication of an Often Neglected Disease.
Normal Skin Microbiota is Altered in Pre-clinical Hidradenitis Suppurativa.
Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions.
Surgical Management of Hidradenitis Suppurativa: Outcomes of 590 Consecutive Patients.
Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa.
Squamous cell carcinoma of the vulva arising in the setting of chronic hidradenitis suppurativa: A case report.
Exploring Coping Strategies for Patients With Hidradenitis Suppurativa.
Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
Ultrasound Diagnosis and Staging in Pediatric Hidradenitis Suppurativa.
Bacterial Biofilm in Acute Lesions of Hidradenitis Suppurativa.
Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases.
Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS).
A Report of Two Patients with Darier Disease and Hidradenitis Suppurativa.
Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa.
Improving outcomes in hidradenitis suppurativa.
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
Association of hidradenitis suppurativa and familial Mediterranean fever: A case series of 6 patients.
Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa.
Interventions for hidradenitis suppurativa: an important step towards evidence-based medicine.
Qualitative study shows disease damage matters to patients with hidradenitis suppurativa.
Hidradenitis suppurativa-acne inversa-like lesions complicating naevus comedonicus: second case supporting the mechanical stress as a triggering factor.
Diagnoses of Hidradenitis Suppurativa in the United States, 1979-2012.
High Copy Numbers of β-Defensin Cluster on 8p23.1, Confer Genetic Susceptibility, and Modulate the Physical Course of Hidradenitis Suppurativa/Acne Inversa.
Hidradenitis Suppurativa: Terminology.
Reply to Revuz' Letter Entitled 'Hidradenitis Suppurativa: Terminology'.
Reduction in pain scores and improvement in depressive symptoms in patients with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial.
The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.
Ustekinumab, another biologic with potential to help patients with hidradenitis suppurativa?
Recalcitrant Hidradenitis Suppurativa: An Investigation of Demographics, Surgical Management, Bacterial Isolates, Pharmacologic Intervention, and Patient-reported Health Outcomes.
Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Cross-Sectional Study of 3,207 Patients.
Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities.
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
Primary Cutaneous Plasmacytosis: Masquerading as Hidradenitis Suppurativa.
Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies.
Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO2) treatment after CO2 excision of hidradenitis suppurativa axillary lesions: A case report.
Beyond the tip of the iceberg: the role of phosphoinositide 3-kinase/AKT in acne inversa/hidradenitis suppurativa.
Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?
Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysis.
PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.
Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions.
Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa.
[Update of hidradenitis suppurativa in Primary Care].
Genetic analysis of NCSTN for potential association with hidradenitis suppurativa in familial and nonfamilial patients.
Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.
Surgical Treatment of Chronic Hidradenitis Suppurativa: CO2 Laser Stripping-Second Intention Technique.
Intralymphatic Proliferation of T-cell Lymphoid Blasts in the Setting of Hidradenitis Suppurativa.
Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa.
Hidradenitis suppurativa: an update.
Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Adopting the orphan: The importance of recognising hidradenitis suppurativa as a systemic auto-inflammatory disease.
Staged Excision in the Outpatient Setting for the Treatment of Axillary Hidradenitis Suppurativa.
Deroofing: An Effective Method for Treating Chronic Diffuse Hidradenitis Suppurativa.
Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.